Dec 03, 2012
2:1
For every share held, investors received 2. The price per share adjusted from $81.03 to $40.52.
The split itself did not change the total investment value.
Haemonetics Corporation (NYSE:HAE) operates in the Medical specialties industry.
Haemonetics Corporation company overviewHaemonetics Corporation's most recent stock split was on December 3, 2012. It was a 2-for-1 forward split, so shareholders received 2 shares for every share they held.
Haemonetics Corporation (NYSE:HAE) has split its stock 2 times: a 2-for-1 split on January 11, 1993 and a 2-for-1 split on December 3, 2012.
Haemonetics Corporation has split its stock 2 times. This history records 2 forward splits between January 11, 1993 and December 3, 2012.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Haemonetics Corporation's 2-for-1 split on December 3, 2012, every share became 2 shares.
Haemonetics Corporation has not announced a new split in our records. Its most recent split was on December 3, 2012, 13 years ago. Companies announce splits in advance, and any new NYSE:HAE split will appear on this page.